{"id":"https://openalex.org/W2897028869","doi":"https://doi.org/10.1016/j.jalz.2018.06.1398","title":"P3\u2010043: TARGETING THE EOTAXIN/CCR3 PATHWAY IN AGING\u2010ASSOCIATED COGNITIVE DECLINE","display_name":"P3\u2010043: TARGETING THE EOTAXIN/CCR3 PATHWAY IN AGING\u2010ASSOCIATED COGNITIVE DECLINE","publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2897028869","doi":"https://doi.org/10.1016/j.jalz.2018.06.1398","mag":"2897028869"},"language":"en","primary_location":{"id":"doi:10.1016/j.jalz.2018.06.1398","doi":"https://doi.org/10.1016/j.jalz.2018.06.1398","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2018.06.1398","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021110313","display_name":"Sakura Minami","orcid":"https://orcid.org/0000-0001-8505-4486","observed_orcids":["https://orcid.org/0000-0001-8505-4486"]},"institutions":[{"id":"https://openalex.org/I4405267265","display_name":"Alkahest, Inc. (United States)","ror":"https://ror.org/01y7mep45","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267265"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"S. Sakura Minami","raw_affiliation_strings":["Alkahest, Inc., San Carlos, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alkahest, Inc., San Carlos, CA, USA","institution_ids":["https://openalex.org/I4405267265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036558068","display_name":"Sanket V. Rege","orcid":"https://orcid.org/0000-0001-9145-1664","observed_orcids":["https://orcid.org/0000-0001-9145-1664"]},"institutions":[{"id":"https://openalex.org/I4405267265","display_name":"Alkahest, Inc. (United States)","ror":"https://ror.org/01y7mep45","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sanket Rege","raw_affiliation_strings":["Alkahest, Inc., San Carlos, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alkahest, Inc., San Carlos, CA, USA","institution_ids":["https://openalex.org/I4405267265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046510177","display_name":"Hannah Hackbart","orcid":"https://orcid.org/0009-0005-9128-9026","observed_orcids":["https://orcid.org/0009-0005-9128-9026"]},"institutions":[{"id":"https://openalex.org/I4405267265","display_name":"Alkahest, Inc. (United States)","ror":"https://ror.org/01y7mep45","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hannah Hackbart","raw_affiliation_strings":["Alkahest, Inc., San Carlos, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alkahest, Inc., San Carlos, CA, USA","institution_ids":["https://openalex.org/I4405267265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075620744","display_name":"Eva Czirr","orcid":"https://orcid.org/0000-0003-0247-0631","observed_orcids":["https://orcid.org/0000-0003-0247-0631"]},"institutions":[{"id":"https://openalex.org/I4405267265","display_name":"Alkahest, Inc. (United States)","ror":"https://ror.org/01y7mep45","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eva Czirr","raw_affiliation_strings":["Alkahest, Inc., San Carlos, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alkahest, Inc., San Carlos, CA, USA","institution_ids":["https://openalex.org/I4405267265"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037456393","display_name":"Steven P. Braithwaite","orcid":"https://orcid.org/0000-0003-0520-8823","observed_orcids":["https://orcid.org/0000-0003-0520-8823"]},"institutions":[{"id":"https://openalex.org/I4405267265","display_name":"Alkahest, Inc. (United States)","ror":"https://ror.org/01y7mep45","country_code":"US","type":"company","lineage":["https://openalex.org/I4405267265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven P. Braithwaite","raw_affiliation_strings":["Alkahest, Inc., San Carlos, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alkahest, Inc., San Carlos, CA, USA","institution_ids":["https://openalex.org/I4405267265"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5021110313"],"corresponding_institution_ids":["https://openalex.org/I4405267265"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.11997289,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"7S_Part_20","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.8539999723434448,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.8539999723434448,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13446","display_name":"Antioxidants, Aging, Portulaca oleracea","score":0.019899999722838402,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.01600000075995922,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/eotaxin","display_name":"eotaxin","score":0.9670000076293945}],"concepts":[{"id":"https://openalex.org/C2777716647","wikidata":"https://www.wikidata.org/wiki/Q5381961","display_name":"Eotaxin","level":4,"score":0.73232102394104},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6124330163002014},{"id":"https://openalex.org/C1423137","wikidata":"https://www.wikidata.org/wiki/Q21113928","display_name":"CCR3","level":5,"score":0.5702993273735046},{"id":"https://openalex.org/C2984863031","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Cognitive decline","level":4,"score":0.5685402750968933},{"id":"https://openalex.org/C2775858765","wikidata":"https://www.wikidata.org/wiki/Q3825161","display_name":"Barnes maze","level":4,"score":0.5566285848617554},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5130042433738708},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.4469361901283264},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4204283356666565},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4181947112083435},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4102977216243744},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.40526071190834045},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.39108750224113464},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3608703911304474},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.35209864377975464},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3324993848800659},{"id":"https://openalex.org/C12823836","wikidata":"https://www.wikidata.org/wiki/Q24720618","display_name":"Chemokine receptor","level":4,"score":0.28330326080322266},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2575835883617401},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.20053598284721375},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.11121952533721924},{"id":"https://openalex.org/C2985665543","wikidata":"https://www.wikidata.org/wiki/Q3560550","display_name":"Spatial learning","level":3,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jalz.2018.06.1398","doi":"https://doi.org/10.1016/j.jalz.2018.06.1398","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2018.06.1398","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's & Dementia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2981096310","https://openalex.org/W2897587545","https://openalex.org/W4327814638","https://openalex.org/W2992739463","https://openalex.org/W4413920644","https://openalex.org/W4313199468","https://openalex.org/W4319433891","https://openalex.org/W4403544223","https://openalex.org/W3036915614","https://openalex.org/W3194929263"],"abstract_inverted_index":{"As":[0],"the":[1,26,83,107,127,162,180,213,225,249,253,260,265],"population":[2],"ages,":[3],"dementia":[4],"and":[5,66,76,101,165,170,183,216,244,275],"aging-related":[6],"diseases":[7,71,280],"are":[8,17],"becoming":[9],"increasingly":[10],"prevalent.":[11],"Mounting":[12],"evidence":[13],"suggests":[14],"that":[15,23,224,246],"there":[16],"factors":[18,35,52],"present":[19],"in":[20,36,62,69,141,146,189,199,204,210,212,229,256,259,277],"young":[21,63,95,151,191],"blood":[22,38],"can":[24],"counteract":[25],"effects":[27,47,135,241],"of":[28,168,269],"brain":[29,158,171],"aging.":[30],"Similarly,":[31],"we":[32,93,222],"have":[33],"identified":[34],"aged":[37,121,205,230],"whose":[39],"increase":[40,255],"with":[41,45,98,126,154,161,207,234,248],"aging":[42],"is":[43,53,67],"associated":[44],"negative":[46],"on":[48,136,179,242],"cognition.":[49],"Among":[50],"these":[51],"eotaxin,":[54],"a":[55,103,111,117],"chemokine":[56],"known":[57],"to":[58,133,156],"induce":[59,157],"cognitive":[60,91,138,202],"deficits":[61],"wild-type":[64],"mice":[65,97,123,153,206,231],"implicated":[68],"aging-associated":[70,278],"such":[72,281],"as":[73,282],"Alzheimer's":[74,283],"disease":[75],"Parkinson's":[77],"disease.":[78,284],"To":[79],"test":[80],"whether":[81],"targeting":[82,106],"primary":[84],"eotaxin":[85,100],"receptor,":[86,109],"CCR3,":[87],"could":[88],"prevent":[89],"eotaxin-induced":[90],"deficits,":[92],"treated":[94,125,150,160],"C57Bl/6":[96,122,152],"recombinant":[99],"co-administered":[102],"small":[104],"molecule":[105],"CCR3":[108,128,163,173,193,235,250,270],"twice":[110],"day":[112],"for":[113,130,187,272],"18":[114],"days.":[115],"In":[116,220],"second":[118],"experiment,":[119],"23-month-old":[120],"were":[124],"antagonist":[129,174,194,236,251],"3":[131],"weeks":[132],"assess":[134],"aging-induced":[137],"dysfunction":[139,227],"driven":[140],"part":[142],"by":[143],"endogenous":[144],"increases":[145],"eotaxin.":[147],"We":[148,238],"also":[149,197],"LPS":[155],"inflammation,":[159],"antagonist,":[164],"assessed":[166],"markers":[167],"peripheral":[169],"inflammation.":[172],"treatment":[175,195,247],"significantly":[176],"improved":[177,233],"performance":[178,211],"Y":[181,214],"maze":[182,185,215,218],"Barnes":[184,217],"tests":[186],"cognition":[188,276],"eotaxin-treated":[190],"mice.":[192],"was":[196,232],"effective":[198],"reversing":[200],"age-associated":[201],"decline":[203],"similar":[208],"improvements":[209],"tests.":[219],"addition,":[221],"found":[223,245],"locomotor":[226],"observed":[228],"treatment.":[237],"then":[239],"investigated":[240],"neuroinflammation,":[243],"prevented":[252],"LPS-induced":[254],"microglial":[257],"activation":[258],"brain.":[261],"These":[262],"results":[263],"implicate":[264],"potential":[266],"therapeutic":[267],"utility":[268],"antagonism":[271],"improving":[273],"neuroinflammation":[274],"neurodegenerative":[279]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2018-10-26T00:00:00"}